JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB178395

Anti-HGF antibody [EPR12230]

Be the first to review this product! Submit a review

|

(18 Publications)

Rabbit Recombinant Monoclonal HGF antibody. Suitable for IP, WB and reacts with Human samples. Cited in 18 publications.

View Alternative Names

HPTA, HGF, Hepatocyte growth factor, Hepatopoietin-A, Scatter factor, SF

5 Images
Immunoprecipitation - Anti-HGF antibody [EPR12230] (AB178395)
  • IP

Unknown

Immunoprecipitation - Anti-HGF antibody [EPR12230] (AB178395)

ab178395 (purified) at 1 : 30 dilution (2μg) immunoprecipitating HGF in Human placenta lysate.
Lane 1 (input) : Human placenta lysate 10μg
Lane 2 (+) : ab178395 & Human placenta lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab178395 in Human placenta lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-HGF antibody [EPR12230] (ab178395)

Predicted band size: 83 kDa

false

Western blot - Anti-HGF antibody [EPR12230] (AB178395)
  • WB

Lab

Western blot - Anti-HGF antibody [EPR12230] (AB178395)

All lanes:

Western blot - Anti-HGF antibody [EPR12230] (ab178395) at 1/200 dilution

All lanes:

Human placenta lysates at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 83 kDa

Observed band size: 83 kDa

false

Western blot - Anti-HGF antibody [EPR12230] (AB178395)
  • WB

Lab

Western blot - Anti-HGF antibody [EPR12230] (AB178395)

All lanes:

Western blot - Anti-HGF antibody [EPR12230] (ab178395) at 1/1000 dilution

All lanes:

U-87 MG (Human glioblastoma-astrocytoma epithelial cell) whole cell lysates at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 83 kDa

Observed band size: 83 kDa

false

Western blot - Anti-HGF antibody [EPR12230] (AB178395)
  • WB

Lab

Western blot - Anti-HGF antibody [EPR12230] (AB178395)

All lanes:

Western blot - Anti-HGF antibody [EPR12230] (ab178395) at 1/1000 dilution

All lanes:

Human HGF (aa 32-728) recombinant protein

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 83 kDa

Observed band size: 60 kDa

false

Western blot - Anti-HGF antibody [EPR12230] (AB178395)
  • WB

CiteAb

Western blot - Anti-HGF antibody [EPR12230] (AB178395)

HGF western blot using anti-HGF antibody [EPR12230] ab178395. Publication image and figure legend from Chen, H., Lin, C., et al., 2020, Cell Death Dis, PubMed 32041944.

ab178395 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab178395 please see the product overview.

The HGF/MET signalling pathway contributes to resistance to alectinib in ALK-positive lung cancer cells.a The concentrations of HGF in the H3122 and H2228 cell culture supernatants with or without alectinib (50 nmol/L) or crizotinib (100 nmol/L) administration were determined by ELISA. The data are presented as the mean ± SD, and the experiment was repeated three times. *p < 0.05; **p < 0.001. b H3122 and H2228 cells were treated with alectinib (50 nmol/L) or crizotinib (100 nmol/L) for the indicated amounts of time, and MET phosphorylation was measured by western blot. c, d H3122 and H2228 cells were transfected with HGF, and the expression of HGF and the phosphorylation levels of MET were determined by western blot. Vec negative control vector. e Cell proliferation in crizotinib-treated and alectinib-treated cells with or without HGF was examined by MTT assay; the IC50 values for crizotinib and alectinib were calculated. The data are presented as the mean ± SD, and the experiment was repeated three times. **p < 0.001. Cri crizotinib, Ale alectinib, Vec negative control vector. f H3122-AR1-6 cells are resistant to alectinib. The alectinib IC50 values of H3122 and H3122-AR cells were detected by MTT assay. The data are presented as the mean ± SD from three independent experiments. **p < 0.001 compared with H3122 cells. g Detection of HGF in the cell culture supernatants of H3122 and H3122-AR cells by ELISA. The data are presented as the mean ± SD from three independent experiments. Asterisks (*) indicates p < 0.05 compared with parental H3122 cells; **p < 0.001 compared with parental H3122 cells. h Immunoblot analysis of ALK, MET, and the phosphorylation of MET in H3122 and H3122-AR cell lines.

false

  • Carrier free

    Anti-HGF antibody [EPR12230] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR12230

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/200", "WB-species-notes": "<p><strong>For unpurified use at 1/1000- 1/5000.</strong></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/200", "WB-species-notes": "<p><strong>For unpurified use at 1/1000- 1/5000.</strong></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/200", "WB-species-notes": "<p><strong>For unpurified use at 1/1000- 1/5000.</strong></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The hepatocyte growth factor (HGF) also known as scatter factor (SF) is a protein with a mass of approximately 83 kDa. This protein is mostly expressed in the liver but it can also be found in other organs such as the kidney and the lungs. HGF acts mechanically by binding to the c-Met receptor activating intracellular signaling mechanisms necessary for various physiological processes. Researchers often use HGF ELISA kits to measure its levels in biological samples and study its various roles.
Biological function summary

HGF plays an essential role in cellular growth regeneration and healing processes across different tissues. It is not part of a complex but functions as a single-chain polypeptide that undergoes cleavage into its active form. HGF facilitates cell proliferation and migration; this is especially important during organ regeneration and repair processes. By engaging with its receptor c-Met it induces cell survival and cytoskeletal reorganization making it important for wound healing.

Pathways

HGF is critical in the MAPK and PI3K-Akt signaling pathways which impact processes like cell division and survival. Through these pathways HGF interacts with other proteins such as ERK and Akt contributing to the regulation of cellular growth and metabolism. HGF's role in these pathways highlights its importance in developmental processes and tissue homeostasis.

HGF displays significant connections to cancer and liver cirrhosis. Its overexpression can lead to the development of various carcinomas due to its effect on cell proliferation and migration. In liver cirrhosis the altered HGF-c-Met signaling might contribute to the disease progression and hepatic dysfunction. Additionally HGF can interact with proteins such as transforming growth factor-beta (TGF-β) in these conditions influencing the pathological environment.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types (PubMed : 20624990). Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization (PubMed : 15167892, PubMed : 20977675). Activates MAPK signaling following TMPRSS13 cleavage and activation (PubMed : 20977675).
See full target information HGF

Publications (18)

Recent publications for all applications. Explore the full list and refine your search

American journal of translational research 17:4952-4963 PubMed40821071

2025

Mesenchymal stem cells promote erlotinib resistance in non-small cell lung cancer through the HGF-AKT/ERK1/2-OPN pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Yang,Jianxin He,Feng Long,Yongqi Liu,Li Lin,Hulai Wei

PloS one 19:e0311801 PubMed39418248

2024

Establishment of a tumor-associated fibroblast associated gene score based on scRNA-seq to predict prognosis in patients with triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Yu,Ziqi Peng,Xing Li,Yiqi Zhang

Cell stress & chaperones 28:253-263 PubMed37052764

2023

ENPP2 alleviates hypoxia/reoxygenation injury and ferroptosis by regulating oxidative stress and mitochondrial function in human cardiac microvascular endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Guanhua Fang,Yanming Shen,Dongshan Liao

BMC cardiovascular disorders 22:578 PubMed36587199

2022

Greater angiogenic and immunoregulatory potency of bFGF and 5-aza-2'-deoxycytidine pre-treated menstrual blood stem cells in compare to bone marrow stem cells in rat model of myocardial infarction.

Applications

Unspecified application

Species

Unspecified reactive species

Mahmood Manshori,Somaieh Kazemnejad,Nasim Naderi,Maryam Darzi,Nahid Aboutaleb,Hannaneh Golshahi

Cell death & disease 13:450 PubMed35546143

2022

TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC.

Applications

Unspecified application

Species

Unspecified reactive species

Huimin Sun,Jianzhong Zheng,Juanjuan Xiao,Juntao Yue,Zhiyuan Shi,Zuodong Xuan,Chen Chen,Yue Zhao,Wenbin Tang,Shaopei Ye,Jinxin Li,Qiumin Deng,Lei Zhang,Feng Zhu,Chen Shao

iScience 25:103984 PubMed35281743

2022

Extracellular vesicles promotes liver metastasis of lung cancer by ALAHM increasing hepatocellular secretion of HGF.

Applications

Unspecified application

Species

Unspecified reactive species

Chunyang Jiang,Xu Li,Bingsheng Sun,Na Zhang,Jing Li,Shijing Yue,Xiaoli Hu

Cell death discovery 8:17 PubMed35013115

2022

Tumor-derived extracellular vesicles inhibit HGF/c-Met and EGF/EGFR pathways to accelerate the radiosensitivity of nasopharyngeal carcinoma cells via microRNA-142-5p delivery.

Applications

Unspecified application

Species

Unspecified reactive species

Changyu Zhu,Xiaolei Jiang,Hua Xiao,Jianmei Guan

Biochemistry and biophysics reports 28:101186 PubMed34977363

2021

A single injection of CM1021, a long half-life hepatocyte growth factor mimetic, increases liver mass in mice.

Applications

Unspecified application

Species

Unspecified reactive species

James H Kelly

Cell biology international 45:2521-2533 PubMed34486197

2021

HGF/c-MET pathway contributes to cisplatin-mediated PD-L1 expression in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zhan-Sheng Zhang,Ruo-Han Yang,Xin Yao,Yue-Ying Cheng,Hong-Xiang Shi,Chao-Yan Yao,Zi-Xuan Gao,De-Fei Qi,Wen-Ke Zhang,Yuan-Yuan Dou,Juan Guo,Meng-Wen Hu,Hui Zhao,Dong Fang

International journal of molecular sciences 21: PubMed32899940

2020

Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.

Applications

Unspecified application

Species

Unspecified reactive species

Olga Kurmyshkina,Pavel Kovchur,Ludmila Schegoleva,Tatyana Volkova
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com